NEW YORK, NY — December 22, 2025 — Impiricus, the leading AI-powered physician engagement platform, was honored this week by the New York Stock Exchange (NYSE) with a featured spotlight on the trading floor. The recognition celebrates the company’s unprecedented 30,000% growth over the past several years and its expanding influence in life sciences.
The NYSE spotlight comes during a landmark week for Impiricus, following a featured appearance on the Nasdaq Tower in Times Square. As the company closes out a record-breaking 2025, the recognition from the world’s premier financial institutions reinforces Impiricus’ position as the new standard for ethical AI in clinical support and physician engagement.
“Being recognized on the floor of the New York Stock Exchange is an incredible milestone for the entire Impiricus team,” said Osama Hashmi MD, Co-founder and CEO of Impiricus. “As we close out 2025, this recognition reinforces our mission: to bridge the gap between breakthrough science and the physicians who deliver it, accelerating treatment access while empowering underserved physicians with the tools to improve patient outcomes.”
During the spotlight event, Impiricus leadership engaged with key figures in the New York financial and biotech communities, including a meeting with Eric Dimise, PhD, Director of Healthcare and Life Sciences at the NYSE. The visit coincided with the NewYorkBIO Life Sciences Showcase, highlighting Impiricus’ integral role in the city’s burgeoning life sciences ecosystem.
“Engagements like these are critical for bridging the gap between the financial community and the emerging companies that are working to revolutionize patient care,” said Sandy Donaldson, Co-founder and Chief Strategy Officer. “At Impiricus, we are proud to be part of the vibrant New York technology and life sciences landscape. We look forward to building on this momentum as we move into a transformative 2026.”
